Lotus Ventures Inc.

J

CA54571Q1081

Pharmaceuticals

Market Closed - Canadian Securities Exchange Other stock markets 16:37:16 28/03/2024 GMT			5-day change	1st Jan Change
0.01 ^CAD	-.--%		-.--%	-33.33%

2023	Lotus Ventures Inc. Launches Joker Juice Cannabis Strain in BC	CI
2023	Lotus Ventures Inc. Reports Earnings Results for the Nine Months Ended May 31, 2023	CI

Lotus Ventures Inc. announced that it has received CAD 5.01805 million in funding

January 21, 2018

On January 22, 2018 Lotus Ventures Inc. (CNSX:J) closed the transactions. The company received a gross proceeds of CAD 5,018,050. The transaction was oversubscribed. The company paid a total finder fees of $115,750.

Latest news about Lotus Ventures Inc.

Lotus Ventures Inc. Launches Joker Juice Cannabis Strain in BC	12-15	CI
Lotus Ventures Inc. Reports Earnings Results for the Nine Months Ended May 31, 2023	02/08/23	CI
Lotus Ventures Inc. Reports Earnings Results for the Half Year Ended February 28, 2023	30/04/23	CI
Lotus Launches Keylime Kush Flower in Ontario Under the Lotus Cannabis Co. Brand	11/04/23	CI
Lotus Ventures Inc. Shares Update on Keylime Kush Sales in British Columbia	10/03/23	MT
Lotus Ventures Inc. Updates on Its Initial Sales Results from the Launch of Its Keylime Kush Flower and Pre-Rolls in British Columbia	10/03/23	CI
Lotus Ventures Inc. Reports Earnings Results for the First Quarter Ended November 30, 2022	28/02/23	CI
Lotus Ventures Inc. Auditor Raises 'Going Concern' Doubt	21/02/23	CI
Lotus Ventures Inc. Reports Earnings Results for the Full Year Ended August 31, 2022	21/02/23	CI
Lotus Launches First Keylime Kush Cultivar Under the Lotus Cannabis Co. Brand in British Columbia	23/01/23	CI
Lotus Ventures Inc. Appoints Albert Duwyn as New Chairman of the Board of Directors	06/10/22	CI
Earnings Flash (LTTSF) LOTUS VENTURES Posts Q3 EPS $0.00	02/08/22	MT
Lotus Ventures Inc. Reports Earnings Results for the Nine Months Ended May 31, 2022	01/08/22	CI
Lotus Ventures Inc. Reports Earnings Results for the Half Year Ended February 28, 2022	29/04/22	CI
Lotus Ventures Inc. Announces Second Official Collaborative Strain Launch with Auxly Cannabis Group Inc	20/04/22	CI
Lotus Ventures Inc. Reports Earnings Results for the First Quarter Ended November 30, 2021	30/01/22	CI
Lotus Ventures Inc. Auditor Raises 'Going Concern' Doubt	28/12/21	CI
Lotus Ventures Inc. Reports Earnings Results for the Full Year Ended August 31, 2021	28/12/21	CI
Lotus Ventures Inc. Accelerates Path to Retail Market Sales Upon Receipt of Standard Processing Licence from Health Canada	08/09/21	CI
Lotus Ventures Inc. Provides Earnings Guidance for the Fifth Quarter of 2022 and Fourth Quarter Ended August 2021	08/09/21	CI
Lotus Ventures Inc. Reports Earnings Results for the Third Quarter Ended May 31, 2021	30/07/21	CI
Lotus Ventures Inc. Reports Earnings Results for the Second Quarter Ended February 28, 2021	29/04/21	CI
Lotus Ventures Inc. Announces Changes to Its Board	16/02/21	CI
Lotus Ventures Inc. Reports Revenue Results for the First Quarter Ended January 31, 2021	01/02/21	CI
Lotus Ventures Inc. Reports Earnings Results for the First Quarter Ended November 30, 2020	29/01/21	CI

Chart Lotus Ventures Inc.

Duration

Period

More charts

Company Profile

Lotus Ventures Inc. is a Canada-based licensed cannabis producer and owner of the Lotus Cannabis Co. brand. The Company primarily cultivates cannabis flowers, which are sold in the wholesale, recreational, and medical markets across Canada. The Company owns and operates a 22,500 square foot indoor cannabis production facility in Armstrong, British Columbia and holds the licenses for cultivation and sale of cannabis in Canada. It has grown several cultivars, including the Keylime Kush, Black Blossom, Tranquil Elephantizer, and Kalifornia. Its Keylime Kush recreational portfolio includes 3.5 gram flower, 14 gram flower, and 3 x 0.5 gram pre-rolls. The Company sells its flagship product, the Keylime Kush, to over 300 retail stores across British Columbia and Ontario.

Sector

Pharmaceuticals

Calendar

30/07/2024 - Q3 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Alternative Medicine

	1st Jan change	Capi.
LOTUS VENTURES INC.	-33.33%	841K
DONG-E-E-JIAO CO.,LTD.	+7.30%	4.69B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.	-31.08%	3.66B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED	-0.71%	3.11B
TASLY PHARMACEUTICAL GROUP CO., LTD	-24.32%	2.65B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD.	-11.35%	2.28B
HENAN LINGRUI PHARMACEUTICAL CO., LTD.	+34.19%	1.78B
ZHEJIANG JOLLY PHARMACEUTICAL CO.,LTD	+33.49%	1.37B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD.	-15.07%	1.39B
PT INDUSTRI JAMU DAN FARMASI SIDO MUNCUL TBK	+40.95%	1.38B